Sarepta Therapeutics, Inc.

Q4 2025 13F Holdings Report, Options Holdings

Signature - Title
Ryan Wong - Executive Vice President, Chief Financial Officer
Location
Cambridge, MA
Options holdings as of
31 Dec 2025
Notional value
$0
Number of holdings
0
Filing time
12 Feb 2026, 20:57:42 UTC
Description
All US holdings of this investor are reported in this report.
Stock holdings
Showing options holdings, see here for stock holdings

Sarepta Therapeutics, Inc. didn't report any options holdings as of Q4 2025. Check stock holdings.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Ryan Wong Executive Vice President, Chief Financial Officer Las Vegas, Nevada 12 Feb 2026